Table 3 Clinical monitoring
Evaluation | Notes |
|---|---|
Summary of routine evaluations | |
Blood (or urine) succinylacetone | |
Blood NTBC concentration | After initiation of treatment |
Plasma amino acids (phenylalanine, tyrosine) | |
CBC: hemoglobin, hematocrit, WBC, platelet count | |
PT/PTT | |
CMP | |
AFP | |
Urine: see renal evaluation below | |
Liver evaluation | |
Serum AFP concentration | |
PT | |
PTT | |
ALT/AST/GGT | One of either ALT or AST is good; GGT if patient is symptomatic |
Bilirubin including direct | |
Albumin | |
Alkaline phosphatase | For rickets; if elevated, consider wrist radiography, consider vitamin D level |
Imaging: ultrasound with periodic MRI or CT(with contrast) | Modality dependent on individual clinical circumstances (see text) |
Renal evaluation | |
Ultrasound | |
Blood chemistries: bicarbonate, BUN, creatinine | |
Blood calcium and phosphate | |
Urine analysis | |
Urine amino acids | |
Urine calcium, phosphate, creatinine (TRP) | |
Urine B2-microglobulin | |
Other evaluation | |
Nutrition assessment | See text for nutrition |
Developmental evaluation/neuropsychology assessment | By school age or as needed |
Ophthalmology: Slit lamp examination | When symptomatic or at increased risk |